A Clinical Research of CD33-Targeted CAR-T in Myeloid Malignancies
NCT02958397
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Myeloid Malignancies
Interventions
BIOLOGICAL:
Anti-CD33-CAR-transduced T cells
Sponsor
Southwest Hospital, China